F
FDA
Guest
FDA grants accelerated approval to dabrafenib in combination with trametinib for unresectable or metastatic solid tumors with BRAF V600E mutation
Baca selengkapnya di : http://www.fda.gov...
Baca selengkapnya di : http://www.fda.gov...